The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aclaris Therapeutics, Inc. | COM | 00461U105 | 13,047,980 | 1,258,243 | SH | SOLE | 1,258,243 | 0 | 0 | ||
Compass Therapeutics, Inc. | COM | 20454B104 | 4,210,546 | 1,324,071 | SH | SOLE | 1,324,071 | 0 | 0 | ||
Disc Medicine, Inc. | COM | 254604101 | 10,811,977 | 243,513 | SH | SOLE | 243,513 | 0 | 0 | ||
Hims & Hers Health, Inc. | COM CL A | 433000106 | 35,093,781 | 3,733,381 | SH | SOLE | 3,733,381 | 0 | 0 | ||
Kinnate Biopharma Inc. | COM | 49705R105 | 10,683,650 | 3,525,957 | SH | SOLE | 3,525,957 | 0 | 0 | ||
Pardes Biosciences Inc | COM | 69945Q105 | 19,569,515 | 10,811,887 | SH | SOLE | 10,811,887 | 0 | 0 | ||
Pharvaris N.V. | COM | N69605108 | 516,910 | 34,142 | SH | SOLE | 34,142 | 0 | 0 | ||
Quantum Si Inc | COM CL A | 74765K105 | 1,654,683 | 924,404 | SH | SOLE | 924,404 | 0 | 0 | ||
Somalogic, Inc. | COM CL A | 83444K105 | 7,861,568 | 3,403,276 | SH | SOLE | 3,403,276 | 0 | 0 | ||
Theseus Pharmaceuticals, Inc. | COM | 88369M101 | 33,451,278 | 3,585,346 | SH | SOLE | 3,585,346 | 0 | 0 |